Literature DB >> 34236327

Giant pulmonary artery aneurysm caused by sibutramine-associated pulmonary arterial hypertension: First case in the literature.

Barkın Kültürsay1, Berhan Keskin1, Ali Karagöz1, Özgür Yaşar Akbal1, Cihangir Kaymaz1.   

Abstract

Entities:  

Year:  2021        PMID： 34236327      PMCID： PMC8274892          DOI： 10.5152/AnatolJCardiol.2021.64166

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN： 2149-2263            Impact factor:   1.596


× No keyword cloud information.
  9 in total

Review 1.  Aneurysms of the pulmonary artery.

Authors:  Maximilian Kreibich; Matthias Siepe; Johannes Kroll; René Höhn; Jochen Grohmann; Friedhelm Beyersdorf
Journal:  Circulation       Date:  2015-01-20       Impact factor: 29.690

Review 2.  Review of the Ongoing Story of Appetite Suppressants, Serotonin Pathway, and Pulmonary Vascular Disease.

Authors:  Isabel S Bazan; Wassim H Fares
Journal:  Am J Cardiol       Date:  2016-03-02       Impact factor: 2.778

Review 3.  Cardiovascular risk-benefit profile of sibutramine.

Authors:  A J Scheen
Journal:  Am J Cardiovasc Drugs       Date:  2010       Impact factor: 3.571

Review 4.  Drug-induced pulmonary arterial hypertension: a review.

Authors:  Lohit Garg; Ghulam Akbar; Sahil Agrawal; Manyoo Agarwal; Leila Khaddour; Rishin Handa; Aakash Garg; Mahek Shah; Brijesh Patel; Bhavinkumar D Dalal
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

5.  Effects of the sibutramine therapy on pulmonary artery pressure in obese patients.

Authors:  A Guven; N Koksal; A Cetinkaya; G Sokmen; R Ozdemir
Journal:  Diabetes Obes Metab       Date:  2004-01       Impact factor: 6.577

6.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

Review 7.  Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.

Authors:  A J Krentz; K Fujioka; M Hompesch
Journal:  Diabetes Obes Metab       Date:  2016-06       Impact factor: 6.577

8.  Aminorex and pulmonary hypertension. A review.

Authors:  H P Gurtner
Journal:  Cor Vasa       Date:  1985

Review 9.  Pulmonary artery aneurysm: a review.

Authors:  Mridul Gupta; Abhinav Agrawal; Annamaria Iakovou; Stuart Cohen; Rakesh Shah; Arunabh Talwar
Journal:  Pulm Circ       Date:  2020-02-28       Impact factor: 3.017
  9 in total
  1 in total

1.  Sulfated Glucan from the Green Seaweed Caulerpa sertularioides Inhibits Adipogenesis through Suppression of Adipogenic and Lipogenic Key Factors.

Authors:  Gildacio Pereira Chaves Filho; Lucas Alighieri Neves Costa Batista; Silvia Regina Batistuzzo de Medeiros; Hugo Alexandre Oliveira Rocha; Susana Margarida Gomes Moreira
Journal:  Mar Drugs       Date:  2022-07-23       Impact factor: 6.085
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.